Diabetes, oxidative stress and therapeutic strategies

L Rochette, M Zeller, Y Cottin, C Vergely - Biochimica et Biophysica Acta …, 2014 - Elsevier
Background Diabetes has emerged as a major threat to health worldwide. Scope of Review
The exact mechanisms underlying the disease are unknown; however, there is growing …

[HTML][HTML] Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus

F Hajiaghaalipour, M Khalilpourfarshbafi… - International journal of …, 2015 - ncbi.nlm.nih.gov
Diabetes mellitus (DM) is a metabolic diseases characterized by hyperglycemia due to
insufficient or inefficient insulin secretory response. This chronic disease is a global problem …

Mechanism of action of natural products used in the treatment of diabetes mellitus

PK Prabhakar, M Doble - Chinese journal of integrative medicine, 2011 - Springer
Diabetes mellitus (DM) is a metabolic disorder caused by insufficient or inefficient insulin
secretary response and it is characterized by increased blood glucose levels …

[HTML][HTML] Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades

C Jiang, L Liang, Y Guo - Acta Pharmacologica Sinica, 2012 - nature.com
This article provides an overview of approximately 300 secondary metabolites with inhibitory
activity against protein tyrosine phosphatase 1B (PTP1B), which were isolated from various …

In vitro characterization and pharmacokinetics of dapagliflozin (BMS-512148), a potent sodium-glucose cotransporter type II inhibitor, in animals and humans

M Obermeier, M Yao, A Khanna, B Koplowitz… - Drug metabolism and …, 2010 - ASPET
(2 S, 3 R, 4 R, 5 S, 6 R)-2-(3-(4-Ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyl-tetrahydro-
2 H-pyran-3, 4, 5-triol (dapagliflozin; BMS-512148) is a potent sodium-glucose cotransporter …

Progress in the discovery of naturally occurring anti-diabetic drugs and in the identification of their molecular targets

JH He, LX Chen, H Li - Fitoterapia, 2019 - Elsevier
Diabetes mellitus (DM), a chronic metabolic disease, severely affects patients' life and
intensively increases risks of developing other diseases. It is estimated that 0.4 billion …

[HTML][HTML] Ginseng and diabetes: the evidences from in vitro, animal and human studies

HD Yuan, JT Kim, SH Kim… - Journal of ginseng …, 2012 - ncbi.nlm.nih.gov
Panax ginseng exhibits pleiotropic beneficial effects on cardiovascular system, central
nervous system, and immune system. In the last decade, numerous preclinical findings …

Fructose‐fed rhesus monkeys: a nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes

AA Bremer, KL Stanhope, JL Graham… - Clinical and …, 2011 - Wiley Online Library
The incidence of insulin resistance has increased dramatically over the past several years,
and we and others have proposed that this increase may at least in part be attributable to …

Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018)

H Hussain, IR Green, G Abbas… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Protein tyrosine phosphatase 1B (PTP1B) inhibition has been recommended
as a crucial strategy to enhance insulin sensitivity in various cells and this fact is supported …

[HTML][HTML] Status of research on natural protein tyrosine phosphatase 1B inhibitors as potential antidiabetic agents: Update

Z Liu, H Gao, Z Zhao, M Huang, S Wang… - Biomedicine & …, 2023 - Elsevier
Protein tyrosine phosphatase 1B (PTP1B) is a crucial therapeutic target for multiple human
diseases comprising type 2 diabetes (T2DM) and obesity because it is a seminal part of a …